Axsome Therapeutics, Inc. (AXSM) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$160
Day's range
$164.99

Axsome Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 05/13/2026 3.91 M $661.35 M   -0.02% 7.87%
05/08/2026 2.06 M $347.87 M   100.00% 4.14%
05/15/2026 1.94 M $327.52 M   100.00% 3.90%
FMR LLC 05/15/2026 1.57 M $264.85 M   32.61% 3.15%
PRICE T ROWE ASSOCIATES INC /MD/ 05/15/2026 1.32 M $222.61 M   -12.77% 2.65%
INVESCO LTD. 05/12/2026 1.30 M $219.33 M   1.90% 2.61%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 1.16 M $196.60 M   15.12% 2.34%
WELLINGTON MANAGEMENT GROUP LLP 05/15/2026 1.15 M $193.58 M   -6.25% 2.30%
DEEP TRACK CAPITAL, LP 05/15/2026 1.10 M $185.92 M   -4.35% 2.21%
STATE STREET CORP 05/15/2026 986.81 K $166.79 M   2.99% 1.98%
ASSENAGON ASSET MANAGEMENT S.A. 04/20/2026 865.96 K $146.36 M   85.04% 1.71%
MACQUARIE MANAGEMENT HOLDINGS, INC. 05/15/2026 812.81 K $137.38 M   -17.85% 1.63%
ADAGE CAPITAL PARTNERS GP, L.L.C. 05/15/2026 737.58 K $124.67 M   100.66% 1.48%
ALETHEA CAPITAL MANAGEMENT, LLC 05/13/2026 649.11 K $109.71 M   -2.93% 1.30%
D. E. SHAW & CO., INC. 05/15/2026 603.47 K $102.00 M   9.90% 1.21%
BANK OF AMERICA CORP /DE/ 05/18/2026 598.09 K $101.09 M   -3.23% 1.20%
FIRST TRUST ADVISORS LP 05/13/2026 577.48 K $97.61 M   1,230.20% 1.16%
UBS GROUP AG 05/05/2026 547.20 K $92.49 M   54.00% 1.10%
EVENTIDE ASSET MANAGEMENT, LLC 05/15/2026 519.56 K $87.78 M   -9.05% 1.04%
MORGAN STANLEY 05/15/2026 476.70 K $80.57 M   -2.95% 0.96%
FRANKLIN RESOURCES INC 05/13/2026 438.49 K $74.11 M   28.00% 0.88%
POINT72 ASSET MANAGEMENT, L.P. 05/15/2026 424.75 K $71.79 M   2,259.85% 0.85%
GOLDMAN SACHS GROUP INC 05/15/2026 421.45 K $71.23 M   40.06% 0.85%
PICTET ASSET MANAGEMENT HOLDING SA 04/22/2026 415.98 K $70.31 M   -4.60% 0.84%
NORTHERN TRUST CORP 05/14/2026 401.46 K $67.85 M   2.82% 0.81%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/15/2026 395.12 K $66.78 M   -1.88% 0.79%
HOOD RIVER CAPITAL MANAGEMENT LLC 05/15/2026 371.50 K $62.79 M   1.45% 0.75%
PRINCIPAL FINANCIAL GROUP INC 05/04/2026 350.49 K $59.24 M   -3.48% 0.70%
NUVEEN, LLC 04/30/2026 335.74 K $56.75 M   -3.86% 0.67%
QUBE RESEARCH & TECHNOLOGIES LTD 05/15/2026 335.33 K $56.68 M   3.04% 0.67%
TWO SIGMA INVESTMENTS, LP 05/15/2026 322.78 K $54.56 M   121.69% 0.65%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 295.14 K $49.88 M   100.00% 0.59%
DRIEHAUS CAPITAL MANAGEMENT LLC 05/15/2026 292.37 K $49.42 M   32.58% 0.59%
CITADEL ADVISORS LLC 05/15/2026 281.50 K $47.58 M   103.67% 0.57%
JPMORGAN CHASE & CO 05/13/2026 270.16 K $43.36 M   15.85% 0.54%
PFM HEALTH SCIENCES, LP 05/15/2026 264.30 K $44.67 M   5.07% 0.53%
LOOMIS SAYLES & CO L P 05/14/2026 256.63 K $43.37 M   -18.63% 0.52%
ORBIMED ADVISORS LLC 05/15/2026 213.92 K $36.16 M   -15.49% 0.43%
SOFINNOVA INVESTMENTS, INC. 05/15/2026 212.75 K $35.96 M   1,634.44% 0.43%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 208.90 K $35.31 M   -25.23% 0.42%
BANK OF NEW YORK MELLON CORP 05/05/2026 206.64 K $34.93 M   -18.99% 0.42%
FRONTIER CAPITAL MANAGEMENT CO LLC 05/15/2026 203.07 K $34.32 M   28.77% 0.41%
SOFINNOVA INVESTMENTS, INC. 05/15/2026 200.00 K $33.80 M   100.00% 0.40%
FIRST TURN MANAGEMENT, LLC 05/15/2026 188.77 K $31.91 M   -8.77% 0.38%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 188.50 K $31.86 M   -39.56% 0.38%
BNP PARIBAS ARBITRAGE, SNC 05/12/2026 188.15 K $31.80 M   -38.19% 0.38%
CITIGROUP INC 05/11/2026 185.66 K $31.38 M   -9.04% 0.37%
VOYA INVESTMENT MANAGEMENT LLC 05/12/2026 183.97 K $31.09 M   6.15% 0.37%
AMERIPRISE FINANCIAL INC 05/15/2026 176.31 K $29.80 M   76.46% 0.35%
RENAISSANCE TECHNOLOGIES LLC 05/14/2026 164.30 K $27.77 M   -3.35% 0.33%

Axsome Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 514 institutional investors and hedge funds held shares of Axsome Therapeutics Inc. The most heavily invested institutionals were:

BlackRock, Inc.: 3.91 M

FMR LLC: 1.57 M

PRICE T ROWE ASSOCIATES INC /MD/: 1.32 M

Invesco Ltd.: 1.3 M

GEODE CAPITAL MANAGEMENT, LLC: 1.16 M

WELLINGTON MANAGEMENT GROUP LLP: 1.15 M

76.21% of Axsome Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 47.31 M shares in the last 24 months. This purchase volume represents approximately $7.78 B in transactions.